LFTD Partners Inc. filings document public-company reporting obligations for the OTCQB parent of Lifted Made and its hemp, wellness, energy and psychoactive-products business. The filing record includes Form 12b-25 disclosure tied to an annual report on Form 10-K, including the registrant’s late-filing notice, accounting-record preparation, independent auditor review process and timing of annual financial reporting.
LFTD Partners Inc. reported Q1 2026 net sales of $9.16M, roughly flat year over year, but recorded a net loss of $4.16M versus $0.30M a year earlier. The loss was driven mainly by a new inventory reserve of $5.06M, including $4.72M against hemp-derived products and $0.34M against 7-hydroxymitragynine inventory, plus a $0.14M impairment of hemp-specific fixed assets.
The company warns that a U.S. law banning intoxicating hemp-derived consumables effective November 12, 2026 could eliminate roughly half or more of revenue and has already led to goodwill and investment impairments in 2025. Management states there is substantial doubt about the company’s ability to continue as a going concern. At March 31, 2026, cash was $2.09M, total assets were $14.45M, liabilities were $5.98M, and shareholders’ equity was $8.47M.
LFTD Partners Inc. reports severe financial and regulatory stress around its Lifted hemp and psychoactive products business. The company has an accumulated deficit of $28,839,889 as of December 31, 2025 and discloses substantial doubt about its ability to continue as a going concern.
New federal legislation banning intoxicating hemp-derived consumables beginning November 2026, plus restrictive state laws and potential DEA and FDA actions, could eliminate roughly half of Lifted’s revenue, force large inventory and receivables write-offs, and render hemp-related fixed assets impaired.
LFTD recorded full impairment of Lifted and Oculus goodwill and its Ablis stake, and wrote down its Bendistillery investment to $99,800. Liquidity depends on Lifted’s volatile cash flows, collectability of distributor receivables, and the uncertain availability of future debt or equity capital in a difficult regulatory and capital-markets environment.
LFTD PARTNERS INC. notified the SEC it will file its Form 10-K late under Rule 12b-25 and expects to file within the allowable extension period. The company cites accounting work needed to address comments from its independent registered public accounting firm and related EDGARization issues.
The filing explains that H.R. 5371’s nationwide ban on intoxicating hemp-derived consumable products (effective language dated November 12, 2026) could “in all likelihood” have a devastating impact on the business, noting hemp-derived products represented approximately 52% of Lifted’s sales for the year ended December 31, 2025. The company recorded goodwill impairment charges that reduced the carrying value of Lifted goodwill of $22,292,767 and Oculus goodwill of $800,027 to zero, and recorded an impairment reducing its $399,200 investment in Ablis to zero.
LFTD Partners (LIFD) reported a profitable Q3 2025, with net sales of $9,056,742 and net income of $634,257, reversing a loss a year ago. Gross profit rose to $4,157,495 on lower operating expenses, lifting income from operations to $1,312,791.
For the nine months, net sales were $28,505,928 and net income was $62,265. Cash and cash equivalents were $1,920,664, with restricted cash of $1,000,000. The company reduced Surety Bank borrowings during Q3, including a $592,050 paydown on its working capital loan. Shares outstanding were 14,822,678 as of November 13, 2025.
Risks increased materially. On November 12, 2025, a federal act was signed that bans intoxicating hemp-derived consumable products nationally on November 12, 2026. Hemp-derived products accounted for approximately 47% of Q3 sales. Management warns the act could trigger goodwill impairments on total goodwill of $23,092,794, potential impairment of a $399,200 investment, and significant inventory write-offs. The company states there is substantial doubt about its ability to continue as a going concern.